Note: The 2012, 2013 publications have not been audited.
Jump to: Publications | Grants and Consultancies | HDR completions
Jock Findlay may be from another institution or only recently joined Deakin University.
2011 External
Latifi, Ardian*, Abubaker, Khalid*, Castrechini, Natalie*, Ward, Alister C., Liongue, Clifford, Dobill, Francoise*, Kumar, Janani, Thompson, Erik W.*, Quinn, Michael A.*, Findlay, Jock K.* and Ahmed, Nuzhat* (2011) Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile, Journal of cellular biochemistry, vol. 112, no. 10, pp. 2850-2864, John Wiley & Sons, Inc., Hoboken N.J. [C1]
ERA journal ID: 2235 – Scopus EID: 2-s2.0-80053211466
Citation counts:Scopus - 22,
Thomson - 22
DRO entry for this publication
2009 External
Colomiere, Michelle, Findlay, Jock*, Ackland, Leigh and Ahmed, Nuzhat* (2009) Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of α6β1 integrin, The international journal of biochemistry and cell biology, vol. 41, no. 5, pp. 1034-1045, Pergamon, Oxford, England [C1]
ERA journal ID: 2222 – Scopus EID: 2-s2.0-59649086123
Citation counts:Scopus - 16,
Thomson - 16
DRO entry for this publication
Colomiere, M., Ward, A. C., Riley, C.*, Trenerry, M. K., Cameron-Smith, D., Findlay, J.*, Ackland, L. and Ahmed, N.* (2009) Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas, British journal of cancer, vol. 100, no. 1, pp. 134-144, Nature Publishing Group, London, England [C1]
ERA journal ID: 15828 – Scopus EID: 2-s2.0-58149218143
Citation counts:Scopus - 55,
Thomson - 55
DRO entry for this publication
No grants and/or consultancies found or audited – the 2012 HERDC financial return has not been completed or loaded as yet.
No completions found or audited.
DRO to publications collection last synchronised: Saturday 18th May 2013 10:04pm